Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72

Vaccine

Volumn 25, Issue 16 SPEC. ISS., 2007, Pages 3219-3227

  Kende, Meir ^a   Tan, Xiaolian ^a   Wlazlowski, Carly ^a   Williams, Rebecca ^a   Lindsey, Changhong ^a   Del Giudice, Giuseppe ^b  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Aerosol ricin challenge; Intranasal vaccination; Mucosal adjuvants; Ricin vaccine

Indexed keywords

ADJUVANT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G2A; LTK 63; LTK63; LTR 72; LTR72; RECOMBINANT CHAIN A RICIN VACCINE; RICIN; UNCLASSIFIED DRUG; VACCINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; LD 50; LUNG INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE; SURVIVAL RATE;

EID: 33947575119     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.036     Document Type: Article

References (19)

1. Spengler B.D. The heat-labile enterotoxin of E. coli. Microbiol Rev 56 (1992) 622-647
2. Clements J.D., Yancy R.J., and Finkelstein R.A. Properties of homogeneous heat-labile enterotoxin from E. coli. Infect Immun 29 (1980) 91-97
3. Jackson R.J., Fujihashi K., Xu Amano J., Kiyono H., Elson C.O., and McGhee J.R. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect Immun 61 (1993) 4272-4279
4. Sixma T.K., Pronk S.E., Kalk K.H., Wartna E.S., van Zanten B.A., Witholt B., et al. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351 (1991) 371-377
5. Holmgren J. Actions of cholera toxin and the prevention and treatment of cholera. Nature 292 (1981) 413-417
6. 32P]ADP-ribosylation of proteins. Methods Enzymol 195 (1991) 267-280
7. Moss J., and Vaughan M. ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins. Adv enzymol Relat Areas Mol Biol 61 (1988) 303-379
8. Suguii S.T. Binding specificities of heat labile enterotoxins isolated from porcine and human enterotoxigenic Escherichia coli for different gangliosides. Can J Microbiol 35 (1989) 670-673
9. Holmgren J., Lonroth I., and Svennerholm L. Tissue receptor for cholera exotoxin postulated structure from studies with GM-1 gangliosyde and related glycolipids. Infect Immun 8 (1973) 208-214
10. Rappuoli R., and Pizza M. Structure and evolutionary aspects of ADP-ribosylating toxins. In: Alouf J., and Freer J. (Eds). Sourcebook of bacterial protein toxins (1991), Academic Press 1-20
11. Moss J., and Vaughan M. Toxin ADP-ribosyltransferases that act on adenylat-cyclase systems. Methods Enzymol 106 (1984) 411-418
12. Field M., Rao M.C., and Chang E.B. Intestinal electrolyte transport and diarrheal disease. N Engl J Med 321 (1989) 800-806
13. Giuliani M.M., Del Giudice G., Giannelli V., Dougan G., Douce G., Rappuoli R., et al. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-rybosyltransferase activity. J Exp Med 187 (1998) 1123-1132
14. Rappuoli R., Pizza M., Douce G., and Dougan G. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol Today 20 (1999) 493-500
15. Brackman J.D., Ott G., and O'Hagan D.T. Intranasal immunization in mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization. Infect Immun 67 (1999) 4276-4279
16. O'Hagen D.T., and Rappuoli R. Novel delivery systems for intranasal immunization with inactivated influenza vaccine. Drug Deliv Syst Sci 1 2 (2001) 41-46
17. Kende M., Del Giudice G., Rivera N., and Hewetsen J. Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant. Vaccine 24 (2006) 2213-2221
18. Guyton A.C. Measurement of respiratory volumes of laboratory animals. Is J Phys 150 (1947) 70-77
19. Hewetson J.F., Rivera P.V., Lemley P.V., Pitt M.L., Cresia D.A., and Thompson W.L. A formalinized toxoid for protection of mice from inhaled ricin. Vaccine 4 (1995) 179-187